Emil Axell
Lund, M 22100, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The chaperone DNAJB6b halts amyloid formation through association with transient Aβ oligomers.
Journal: Physical chemistry chemical physics : PCCP
Published: May 01, 2026
Human chaperone DNAJB6b suppresses tau fibril formation through co-aggregation.
Journal: Communications chemistry
Published: January 26, 2026
Solubility and Metastability of the Amyloidogenic Core of Tau.
Journal: ACS chemical neuroscience
Published: January 23, 2026
General integrated rate law for complex self-assembly reactions reveals the mechanism of amyloid-beta coaggregation.
Journal: Physical chemistry chemical physics : PCCP
Published: September 26, 2025
On the reversibility of amyloid fibril formation.
Journal: Biophysics reviews
Published: September 02, 2024
Structural defects in amyloid-β fibrils drive secondary nucleation.
Journal: Nature communications
Published: June 29, 2024
The role of shear forces in primary and secondary nucleation of amyloid fibrils.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 14, 2024
The Ability of DNAJB6b to Suppress Amyloid Formation Depends on the Chaperone Aggregation State.
Journal: ACS chemical neuroscience
Published: April 19, 2024
A label-free high-throughput protein solubility assay and its application to Aβ40.
Journal: Biophysical chemistry
Published: October 02, 2023
Proliferation of Tau 304-380 Fragment Aggregates through Autocatalytic Secondary Nucleation.
Journal: ACS chemical neuroscience
Published: November 16, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026